🇺🇸 Rebamide in United States
13 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 13
Most-reported reactions
- Rash — 3 reports (23.08%)
- Diarrhoea — 2 reports (15.38%)
- Anaemia — 1 report (7.69%)
- Arthralgia — 1 report (7.69%)
- Asphyxia — 1 report (7.69%)
- Bacterial Infection — 1 report (7.69%)
- Bronchitis — 1 report (7.69%)
- Chronic Sinusitis — 1 report (7.69%)
- Depressed Level Of Consciousness — 1 report (7.69%)
- Drug Eruption — 1 report (7.69%)
Other Other approved in United States
Frequently asked questions
Is Rebamide approved in United States?
Rebamide does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Rebamide in United States?
Chonnam National University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.